CFU-S assay: a historical single-cell assay that offers modern insight to clonal hematopoiesis

Author(s):  
Alessandra Rodriguez y Baena ◽  
Bryce A. Manso ◽  
E. Camilla Forsberg
2020 ◽  
Author(s):  
A Komkov ◽  
A Miroshnichenkova ◽  
A Smirnova ◽  
E Komech ◽  
E Atapina ◽  
...  

Blood ◽  
1981 ◽  
Vol 57 (1) ◽  
pp. 22-24
Author(s):  
ME Miller ◽  
LA Boxer ◽  
EJ Kawaoka ◽  
WA Border

Cell elastimetry has been applied to the measurement of antineutrophil antibodies. This technique measures, under direct visualization, the negative pressure required of aspirate PMNs into small-pored pipettes. Two groups of studies were carried out: (A) In the first group of studies, normal PMNs were incubated with 1 of 8 known antineutrophil serums. Each serum significantly decreased membrane deformability-- i.e., cells became more rigid. The study was conducted in an entirely blind fashion. Randomly coded serums from patients and controls were studied for deformability by observers unaware of the code. (B) In the second group of studies, sera containing immune complexes were incubated with normal PMNs. No significant effects were noted upon deformability. As a single cell assay that partially reflects membrane rigidity, elastimetry may, therefore, have potential in the further characterization of mechanisms by which such antineutrophil antibodies compromise neutrophil functions.


Author(s):  
Miyu Terada ◽  
Sachiko Ide ◽  
Toyohiro Naito ◽  
Niko Kimura ◽  
Michiya Matsusaki ◽  
...  

2020 ◽  
Vol 4 (5) ◽  
pp. 943-952 ◽  
Author(s):  
Asiri Ediriwickrema ◽  
Alexey Aleshin ◽  
Johannes G. Reiter ◽  
M. Ryan Corces ◽  
Thomas Köhnke ◽  
...  

Abstract Although most patients with acute myeloid leukemia (AML) achieve clinical remission with induction chemotherapy, relapse rates remain high. Next-generation sequencing enables minimal/measurable residual disease (MRD) detection; however, clinical significance is limited due to difficulty differentiating between pre-leukemic clonal hematopoiesis and frankly malignant clones. Here, we investigated AML MRD using targeted single-cell sequencing (SCS) at diagnosis, remission, and relapse (n = 10 relapsed, n = 4 nonrelapsed), with a total of 310 737 single cells sequenced. Sequence variants were identified in 80% and 75% of remission samples for patients with and without relapse, respectively. Pre-leukemic clonal hematopoiesis clones were detected in both cohorts, and clones with multiple cooccurring mutations were observed in 50% and 0% of samples. Similar clonal richness was observed at diagnosis in both cohorts; however, decreasing clonal diversity at remission was significantly associated with longer relapse-free survival. These results show the power of SCS in investigating AML MRD and clonal evolution.


Author(s):  
Wesley T Abplanalp ◽  
Sebastian Cremer ◽  
David John ◽  
Jedrzej Hoffmann ◽  
Bianca Schuhmacher ◽  
...  

Rationale: Clonal hematopoiesis (CH) driven by mutations of DNA methyltransferase 3a (DNMT3A) is associated with increased incidence of cardiovascular disease and poor prognosis of patients with chronic heart failure (HF) and aortic stenosis. Although experimental studies suggest that DNMT3A CH-driver mutations may enhance inflammation, specific signatures of inflammatory cells in humans are missing. Objective: To define subsets of immune cells mediating inflammation in humans using single-cell RNA-sequencing. Methods and Results: Transcriptomic profiles of peripheral blood mononuclear cells were analysed in N=6 HF patients harboring DNMT3A CH-driver mutations and N=4 patients with HF and no DNMT3A mutations by single-cell RNA-sequencing. Monocytes of HF patients carrying DNMT3A mutations demonstrated a significantly increased expression of inflammatory genes compared to monocytes derived from HF patients without DNMT3A mutations. Among the specific up-regulated genes were the prototypic inflammatory interleukin (IL) IL1B, IL6, IL8, the inflammasome NLRP3, and the macrophage inflammatory proteins CCL3 and CCL4 as well as resistin, which augments monocyte-endothelial adhesion. Silencing of DNMT3A in monocytes induced a paracrine pro-inflammatory activation and increased adhesion to endothelial cells. Furthermore, the classical monocyte subset of DNMT3A mutation carriers showed increased expression of T-cell stimulating immunoglobulin superfamily members CD300LB, CD83, SIGLEC12, as well as the CD2 ligand and cell adhesion molecule CD58, all of which may be involved in monocyte-T cell interactions. DNMT3A mutation carriers were further characterized by increased expression of the T-cell alpha receptor constant chain and Th1, Th2, Th17, CD8+ effector, CD4+ memory and Treg specific signatures. Conclusions: This study demonstrates that circulating monocytes and T-cells of HF patients harboring CH-driver mutations in DNMT3A exhibit a highly inflamed transcriptome, which may contribute to the aggravation of chronic heart failure.


Lab on a Chip ◽  
2020 ◽  
Vol 20 (15) ◽  
pp. 2765-2775 ◽  
Author(s):  
Jehangir Cama ◽  
Margaritis Voliotis ◽  
Jeremy Metz ◽  
Ashley Smith ◽  
Jari Iannucci ◽  
...  

A novel, rapid single-cell assay for quantifying antibiotic accumulation in Gram-negative bacteria reveals important insights about bacterial drug accumulation.


2007 ◽  
Author(s):  
Sung-Woo Lee ◽  
In-Hye Lee ◽  
Sung-Shin Ryu ◽  
Seung-Min Kwak ◽  
Kyeong-Sik Shin ◽  
...  
Keyword(s):  

Biochemistry ◽  
2004 ◽  
Vol 43 (6) ◽  
pp. 1599-1608 ◽  
Author(s):  
Huaina Li ◽  
Christopher E. Sims ◽  
Milota Kaluzova ◽  
Eric J. Stanbridge ◽  
Nancy L. Allbritton

1994 ◽  
Vol 3 (5) ◽  
pp. 375-380 ◽  
Author(s):  
K. Murayama ◽  
M. Sawamura ◽  
H. Murakami ◽  
J. Tamura ◽  
T. Naruse ◽  
...  
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document